Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04681248
Title Expanded Access Use of DKN-01 for the Treatment of Advanced Solid Tumors
Recruitment Available
Gender both
Phase Expanded access
Variant Requirements No
Sponsors Leap Therapeutics, Inc.
Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.